FDA-cleared profile

BioticsAI

Bioticsai, Inc. · Ultrasound · FDA-cleared (510(k))

Authorized purpose: BioticsAI assists healthcare professionals during and after fetal ultrasound acquisition and interpretation by detecting views and anatomical structures and facilitating quality-criteria verification on DICOM images and frames; it is a concurrent reading aid for the labeled GE ultrasound and prenatal population.

Clinical role
Concurrent reading and image-processing support during and after fetal anatomy examination
Images and patients
Ultrasound · Obstetric/Fetal
Key limitation
Keep in mind: Validated only with GE ultrasound; not intended for maternal ages outside 18-44 or gestation below 18 weeks, with validation covering 18-39 weeks. Quality assessment concerns expected structure presence. An unrecognized structure requires clinical review and does not itself establish a fetal anomaly.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: BioticsAI assists healthcare professionals during and after fetal ultrasound acquisition and interpretation by detecting views and anatomical structures and facilitating quality-criteria verification on DICOM images and frames; it is a concurrent reading aid for the labeled GE ultrasound and prenatal population.
  • Which images or clinical context are in scope?Modality: Ultrasound Anatomy or clinical context: Obstetric/Fetal Input: Still fetal ultrasound DICOM instances or individual frames from multiframe instances from GE ultrasound devices; images are submitted during or after the examination.
  • Who uses it?Intended users: Healthcare professionals including sonographers, OB/GYNs, maternal-fetal medicine specialists and fetal surgeons
  • What does the software produce?Output: AI-1 high-level anatomy labels, AI-2 per-class top-1 fetal plane labels, and AI-3 anatomical structure labels. Green/red/yellow indicators distinguish detected, not-detected and manual-verification items; DICOM viewing and report templates support DICOM SR export.
  • What is its most important limitation?Key limitation: Validated only with GE ultrasound; not intended for maternal ages outside 18-44 or gestation below 18 weeks, with validation covering 18-39 weeks. Quality assessment concerns expected structure presence. An unrecognized structure requires clinical review and does not itself establish a fetal anomaly.

Clinical takeaway. Clinical role: BioticsAI assists healthcare professionals during and after fetal ultrasound acquisition and interpretation by detecting views and anatomical structures and facilitating quality-criteria verification on DICOM images and frames; it is a concurrent reading aid for the labeled GE ultrasound and prenatal population.

Evidence takeaway. Evidence from the reviewed source record: The exact FDA document reports standalone performance testing on 11,186 fetal ultrasound images from 296 patients at a single US site, independent of model development data. Across all image qualities, detection of 5 high-level fetal anatomy sections had sensitivity 0.934 (95% CI 0.929, 0.94) and specificity 0.989 (0.988, 0.99); per-class top-1 detection of 13 fetal planes had sensitivity 0.960 (0.955, 0.964) and specificity 0.997 (0.997, 0.998). Fetal anatomical structure classification results are also reported. Results are as reported in the FDA submission, not independent validation.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
BioticsAI assists healthcare professionals during and after fetal ultrasound acquisition and interpretation by detecting views and anatomical structures and facilitating quality-criteria verification on DICOM images and frames; it is a concurrent reading aid for the labeled GE ultrasound and prenatal population.
  • Exact FDA submission
  • Checked 2026-09-05
Workflow role
Concurrent reading and image-processing support during and after fetal anatomy examination
  • Exact FDA submission
  • Checked 2026-09-05
Required input
Still fetal ultrasound DICOM instances or individual frames from multiframe instances from GE ultrasound devices; images are submitted during or after the examination.
  • Exact FDA submission
  • Checked 2026-09-05
Output and clinician action
AI-1 high-level anatomy labels, AI-2 per-class top-1 fetal plane labels, and AI-3 anatomical structure labels. Green/red/yellow indicators distinguish detected, not-detected and manual-verification items; DICOM viewing and report templates support DICOM SR export.
  • Exact FDA submission
  • Checked 2026-09-05
Care setting
Professional prenatal ultrasound/OB-GYN care; maternal ages 18-44 and fetal images at 18-39 weeks' gestation
  • Exact FDA submission
  • Checked 2026-09-05

Replaces the baseline's generic Pediatric population with exact maternal/gestational bounds. Typical second-trimester anatomy exams are described.

Intended users
Healthcare professionals including sonographers, OB/GYNs, maternal-fetal medicine specialists and fetal surgeons
  • Exact FDA submission
  • Checked 2026-09-05
Limitations
Validated only with GE ultrasound; not intended for maternal ages outside 18-44 or gestation below 18 weeks, with validation covering 18-39 weeks. Quality assessment concerns expected structure presence. An unrecognized structure requires clinical review and does not itself establish a fetal anomaly.
  • Exact FDA submission
  • Checked 2026-09-05

The comparison table says Real Time: No, despite real-time wording elsewhere in the description; no streaming or latency guarantee is assigned.

Evidence summary
The exact FDA document reports standalone performance testing on 11,186 fetal ultrasound images from 296 patients at a single US site, independent of model development data. Across all image qualities, detection of 5 high-level fetal anatomy sections had sensitivity 0.934 (95% CI 0.929, 0.94) and specificity 0.989 (0.988, 0.99); per-class top-1 detection of 13 fetal planes had sensitivity 0.960 (0.955, 0.964) and specificity 0.997 (0.997, 0.998). Fetal anatomical structure classification results are also reported. Results are as reported in the FDA submission, not independent validation.
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "BioticsAI conducted a standalone performance testing on a dataset of 11,186 fetal ultrasound images in the United States across 296 patients" … "population from a single site (across multiple ultrasound screening units and machine instances) in the United States. This dataset was independent of the data used during model development". Read from the exact FDA decision document on 2026-11-14.

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
The exact FDA document reports standalone performance testing on 11,186 fetal ultrasound images from 296 patients at a single US site, independent of model development data. Across all image qualities, detection of 5 high-level fetal anatomy sections had sensitivity 0.934 (95% CI 0.929, 0.94) and specificity 0.989 (0.988, 0.99); per-class top-1 detection of 13 fetal planes had sensitivity 0.960 (0.955, 0.964) and specificity 0.997 (0.997, 0.998). Fetal anatomical structure classification results are also reported. Results are as reported in the FDA submission, not independent validation.
  • FDA source
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "BioticsAI conducted a standalone performance testing on a dataset of 11,186 fetal ultrasound images in the United States across 296 patients" … "population from a single site (across multiple ultrasound screening units and machine instances) in the United States. This dataset was independent of the data used during model development". Read from the exact FDA decision document on 2026-11-14.

Reported sensitivity
93.4% (95% bootstrap CI 92.9-94.0%) for AI-1 detection of five high-level fetal anatomy sections across all image qualities
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05

Table 7; 11,186 images from 296 patients at one US site, K250959 model. This is anatomy classification, not fetal-anomaly diagnostic sensitivity.

Reported specificity
98.9% (95% bootstrap CI 98.8-99.0%) for AI-1 detection of five high-level fetal anatomy sections across all image qualities
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05

Same Table 7 anatomy-classification endpoint and dataset; not a global anomaly-detection specificity.

High-level anatomy sensitivity

93.4 percent

  • EndpointAI-1 detection of abdomen, face, head, limbs and thorax sections across all image qualities, FDA Table 7
  • Population11,186 fetal ultrasound images from 296 patients at one US site; GE acquisitions within labeled maternal/gestational ranges
  • Tested versionBioticsAI model submitted in K250959

High-level anatomy specificity

98.9 percent

  • EndpointAI-1 detection of abdomen, face, head, limbs and thorax sections across all image qualities, FDA Table 7
  • Population11,186 fetal ultrasound images from 296 patients at one US site; GE acquisitions within labeled maternal/gestational ranges
  • Tested versionBioticsAI model submitted in K250959

K250959 BioticsAI standalone classification validation

  • DesignManufacturer held-out standalone testing across anatomy, plane and anatomical-structure classification tasks
  • Population11,186 images from 296 patients at one US site, including variation in BMI, ethnicity, gestational age, twins and abnormalities
  • Scopeexact submission
  • Tested versionBioticsAI configuration in K250959
  • Samplen=296
  • Sites1
  • IndependenceSponsor or vendor study

K250959

Multiple imaging units at a single site. Dataset excluded development/operating-point selection data. Reference-annotation details remain incompletely abstracted; no prospective patient-outcome claim is made.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-04

No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.

Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not verified: Pricing information is recorded but not verified against a resolving source.

Reimbursement

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: Still fetal ultrasound DICOM instances or individual frames from multiframe instances from GE ultrasound devices; images are submitted during or after the examination.

    Scope: Exact FDA submission.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-05 · FDA 510(k) K250959: BioticsAI

  2. Routing

    Source context, not route validation: Client-provided DIMSE connectivity exports ultrasound DICOM to the BioticsAI DICOM Adapter; populated reports can be exported to the clinic PACS as DICOM SR over DIMSE.

    Scope: Exact FDA submission.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-05 · FDA 510(k) K250959: BioticsAI

  3. AI processing

    Source context, not route validation: Cloud-based SaaS accessed through an internet browser; Google Chrome is recommended in the summary.

    Scope: Exact FDA submission. Preserves the known cloud baseline without inferring region, retention or SLA.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-09-05 · FDA 510(k) K250959: BioticsAI

  4. Returned objects

    Source context, not route validation: AI-1 high-level anatomy labels, AI-2 per-class top-1 fetal plane labels, and AI-3 anatomical structure labels. Green/red/yellow indicators distinguish detected, not-detected and manual-verification items; DICOM viewing and report templates support DICOM SR export.

    Scope: Exact FDA submission.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-05 · FDA 510(k) K250959: BioticsAI

  5. Viewer/worklist/report

    Unresolved route: AI-1 high-level anatomy labels, AI-2 per-class top-1 fetal plane labels, and AI-3 anatomical structure labels. Green/red/yellow indicators distinguish detected, not-detected and manual-verification items; DICOM viewing and report templates support DICOM SR export.

    Scope: Exact FDA submission.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-05 · FDA 510(k) K250959: BioticsAI

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
Cloud-based SaaS accessed through an internet browser; Google Chrome is recommended in the summary.
  • Exact FDA submission
  • Checked 2026-09-05

Preserves the known cloud baseline without inferring region, retention or SLA.

Integration
Client-provided DIMSE connectivity exports ultrasound DICOM to the BioticsAI DICOM Adapter; populated reports can be exported to the clinic PACS as DICOM SR over DIMSE.
  • Exact FDA submission
  • Checked 2026-09-05

Official product-family workflow

BioticsAI's official site describes fetal-screening completeness/quality assessment and report generation, and provides a demonstration request route.

product family · checked 2026-09-05

Broader marketing statements about identifying fetal anomalies and real-time feedback are not treated as exact K250959 indications or validated outcomes.

DICOM SR reporting

Report templates can export populated DICOM SR to the clinic PACS via DIMSE.

exact submission · checked 2026-09-05
Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K250959
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
Ultrasound
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05
Anatomy
Obstetric/Fetal
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2025-12-22
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-05Last searched
23Fields reviewed
11Source classes checked
1Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads

Stored prospective fetal-anatomy classification title/date screened. Live page established citation DOI 10.1002/ijgo.70779, but subsequent abstract retrieval was blank. Exact tested device/version and methods remain unresolved; no study or metric promoted. Stored trial array empty. The current discovery snapshot contains 1 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, acr ai central product, vendor product page, literature index, trial registry, stored candidate metadata, stored recall candidates, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not verified - checked 2026-09-05 - Exact FDA submission

    The official site offers demo/sales contact but no verified price, unit, minimum volume or implementation/support fee for K250959.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-10-26 - Exact FDA submission

    Bounded web search on 2026-10-26 (query: "Bioticsai reimbursement CPT"; top results reviewed) found no vendor or payer page stating coding, coverage or payment for this product. No result was a vendor or payer page naming this product with coding or payment; any results were general billing guidance. This records what was found, not that none exists.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Security: Not verified - checked 2026-09-05 - Exact FDA submission

    Regulatory cybersecurity testing and cloud descriptions do not establish a current scoped attestation, retention policy, region or installed access controls.

  • Installation timeline: Not yet reviewed
  • Training: Not verified - checked 2026-09-05 - Exact FDA submission

    Exact onboarding, competency, handling of unsupported views and support commitments require current vendor documentation.

  • Monitoring: Not verified - checked 2026-09-05 - Exact FDA submission

    Editorial acceptance questions: verify missing-view/manual-review handling, maternal/gestational eligibility and DICOM SR export against local protocols; no supplied monitoring service is verified.

7 sources - 3 history items

Source ledger

  1. FDA 510(k) K250959: BioticsAI

    U.S. Food and Drug Administration - Accessed 2026-09-05

    Scope: identity, clinicalUse, modality, anatomy, implementationCapabilities, evidenceStudies, reportedSensitivity, reportedSpecificity

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. BioticsAI model card (K250959)

    American College of Radiology - Published 2026-08-17 - Accessed 2026-09-01

    Scope: intendedUsers, careSetting, output, reportedSensitivity, reportedSpecificity, evidenceSummary, integration, anatomy, evidenceStudies, implementationCapabilities

  4. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  5. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. BioticsAI official fetal ultrasound workflow page

    BioticsAI - Accessed 2026-09-05

    Scope: productFamily, implementationCapabilities

Research history

  1. K250959 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    human reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K261519

Sonio Suspect

Sonio

Authorized purpose: Concurrent physician reading aid for specified abnormal fetal ultrasound findings; patient management must not rely solely on the analysis.

Modality
Ultrasound
Anatomy
Obstetric/Fetal
Decision
2026-06-04
FDA-cleared K252148

Butterfly Gestational Age Tool

Butterfly Network, Inc.

Authorized purpose: Butterfly Gestational Age Tool estimates gestational age for a singleton intrauterine pregnancy presumed to be 16 to 37 weeks within the labeled Butterfly ultrasound workflow; qualified professionals must review the output.

Modality
Ultrasound
Anatomy
Obstetric/Fetal
Decision
2026-03-27
FDA-cleared K243614

Sonio Suspect

Sonio

Authorized purpose: Concurrent or post-exam fetal ultrasound aid that identifies and characterizes eight abnormal findings for interpreting-physician review; not the sole basis for management.

Modality
Ultrasound
Anatomy
Obstetric/Fetal
Decision
2025-02-21

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history